Anti-Cytochrome P450 2R1 [M26-P6H1]
Invented by Ayham Alnabulsi from Vertebrate Antibodies Limited
Invented at Vertebrate Antibodies Limited
- Datasheet
- References (2)
- Inventor Info
Info
Catalogue Number | 152121 |
Applications | ELISA IHC WB |
Antigen/Gene or Protein Targets | CYP2R1, Cytochrome P450, family 2, subfamily R, polypeptide 1. |
Reactivity | Human and Mouse |
Relevance | Cytochrome P450 2R1 (CYP2R1) encodes a member of the cytochrome P450 superfamily of enzymes that are a group of heme-thiolate monooxygenases. Cytochromes P450 catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. CYP2R1 expressed in the liver is a microsomal vitamin D hydroxylase that converts vitamin D into 25-hydroxyvitamin D (calcidiol), the major circulatory form of the vitamin. |
Host | Mouse |
Immunogen | Ovalbumin-conjugated synthetic peptide QPYLICAERR (C-terminal sequence). |
Positive Control | IHC: formalin-fixed, paraffin-embedded human kidney sections. WB: pooled liver microsomes. |
Subclass | IgG1 lambda |
Myeloma Used | P3X63Ag8.653 |
Recommended Growing Conditions | Dulbecco’s media containing 20% Fetal Bovine serum (DH20) prepared as follows (for final volume of 300ml: 237ml DMEM plus 60 ml Fetal Bovine Serum plus 3ml L-Glutamine). |
Notes | This antibody was applied in a poster presented at the 2015 NCRI conference: http://abstracts.ncri.org.uk/?s=oxysterol&year_published=2015 |
Research Area | Cancer, Cardiovascular, Cell Signaling & Signal Transduction, Metabolism |
References: 2 entries
Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer.
Europe PMC ID: 27341022
Swan et al. 2016. Oncotarget. :. PMID: 27341022.
IHC WB
Add a reference
References: 2 entries
Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer.
Swan et al. 2016. Oncotarget. :. PMID: 27341022.
IHC WB
Add a reference